title: [Role of the urologist in the screening of bone diseases].
abstract: During their lifetime, 20% of men will suffer from a fracture secondary to osteoporosis, and morbidity and mortality of a hip fracture in men are more severe than in women. Despite these facts, there are only few studies on osteoporosis in men. Hyopgonadism is a known risk factor for bone mineral density decrease. Hypogonadism can be found in patients diagnosed with prostate cancer who are receiving androgen deprivation therapy, but can also be discovered in patients with male infertility or erectile dysfunction. Urologists have central role in men's health aftercare, and therefore have key role in the screening and in the multidisciplinary treatment of osteoporosis and osteopenia.
authors.affiliation: Service d'urologie, CHUV, Lausanne. Massimo.Valerio@chuv.ch
authors.forename: Massimo
authors.initials: M
authors.lastname: Valerio
authors.forename: Olivier
authors.initials: O
authors.lastname: Lamy
authors.forename: Darius A
authors.initials: DA
authors.lastname: Paduch
authors.forename: Patrice
authors.initials: P
authors.lastname: Jichlinski
authors.forename: Laurent
authors.initials: L
authors.lastname: Vaucher
mesh_terms: D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors; D014572:Urology